MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-28, TFX made $913,021,000 in revenue. -$408,892,000 in net income. Net profit margin of -44.78%.

Income Overview

Revenue
$913,021,000
Net Income
-$408,892,000
Net Profit Margin
-44.78%
EPS
-$9.24
Unit: Dollar
Revenue Breakdown
    • Interventional
    • Vascular Access
    • Surgical
    • Others
Revenue Breakdown
    • Americas Segment
    • EMEASegment
    • Asia Segment

Unit: Dollar
Income Statement
2025-09-28
2025-06-29
2025-03-30
2024-12-31
Net revenues
913,021,000 780,889,000 700,669,000 795,409,000
Cost of goods sold
461,379,000 349,804,000 311,230,000 355,494,000
Gross profit
451,642,000 431,085,000 389,439,000 439,915,000
Selling, general and administrative expenses
281,764,000 215,081,000 222,710,000 254,553,000
Research and development expenses
57,228,000 38,521,000 36,404,000 44,553,000
Pension settlement (benefit) charge
0 0 -0
Goodwill impairment
403,925,000 --60,000,000
Restructuring charges, separation costs and other impairment charges
117,623,000 22,172,000 4,755,000 11,192,000
(loss) income from continuing operations before interest and taxes
-408,898,000 155,311,000 125,570,000 -110,383,000
Interest expense
31,841,000 21,708,000 18,544,000 20,828,666.667
Interest income
2,163,000 1,643,000 1,917,000 2,258,000
(loss) income from continuing operations before taxes
-438,576,000 135,246,000 108,943,000 -126,760,000
(benefit) taxes on (loss) income from continuing operations
-29,699,000 12,662,000 13,839,000 9,902,000
(loss) income from continuing operations
-408,877,000 122,584,000 95,104,000 -136,662,000
Operating (loss) income from discontinued operations
-20,000 -4,000 -133,000 5,000
(benefit) taxes on operating (loss) income from discontinued operations
-5,000 0 -31,000 -1,000
(loss) income from discontinued operations
-15,000 -4,000 -102,000 6,000
Net (loss) income
-408,892,000 122,580,000 95,002,000 -136,656,000
Basic (in shares)
44,237,000 44,269,000 45,782,000 -94,106,000
Diluted (in shares)
44,237,000 44,332,000 45,926,000 -94,673,000
Net (loss) income (in dollars per share)
-9.24 2.77 2.08 -2.91
Net (loss) income (in dollars per share)
-9.24 2.77 2.07 -2.89
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) income-$408,892,000 (loss) income fromdiscontinued operations-$15,000 (loss) income fromcontinuing operations-$408,877,000 (benefit) taxes onoperating (loss) income...-$5,000 (benefit) taxes on (loss)income from continuing...-$29,699,000 Other$79,078,000 Oem$80,412,000 Interventional Urology$71,770,000 Surgical$122,879,000 Anesthesia$101,449,000 Interventional$266,412,000 Vascular Access$191,021,000 Operating (loss) incomefrom discontinued...-$20,000 (loss) income fromcontinuing operations...-$438,576,000 Interest income$2,163,000 Net revenues$913,021,000 Interest expense$31,841,000 (loss) income fromcontinuing operations...-$408,898,000 Gross profit$451,642,000 Cost of goods sold$461,379,000 Restructuring charges,separation costs and other...$117,623,000 Goodwill impairment$403,925,000 Research and developmentexpenses$57,228,000 Selling, general andadministrative expenses$281,764,000

TFX_BIG-svg

TELEFLEX INC (TFX)

TFX_BIG-svg

TELEFLEX INC (TFX)